According to Aspen Pharmacare's latest financial reports the company has $0.47 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-06-30 | $0.38 B | -35.98% |
2021-06-30 | $0.59 B | 44.65% |
2020-06-30 | $0.41 B | -35.44% |
2019-06-30 | $0.63 B | -21.7% |
2018-06-30 | $0.81 B | -1.11% |
2017-06-30 | $0.82 B | 11.66% |
2016-06-30 | $0.73 B | 4.33% |
2015-06-30 | $0.70 B | -8.95% |
2014-06-30 | $0.77 B | 27.63% |
2013-06-30 | $0.60 B | 49.68% |
2012-06-30 | $0.40 B | -9.31% |
2011-06-30 | $0.44 B | 16.95% |
2010-06-30 | $0.38 B | 43.27% |
2009-06-30 | $0.26 B | 37.66% |
2008-06-30 | $0.19 B | -59.45% |
2007-06-30 | $0.47 B | 445.5% |
2006-06-30 | $87.88 M | 32.99% |
2005-06-30 | $66.07 M | -13.09% |
2004-06-30 | $76.02 M | 140.68% |
2003-06-30 | $31.58 M |